Tatiana Coelho de Sampaio, a biologist at the Federal University of Rio de Janeiro, has stated that a pre-print article discussing polylaminin as a potential treatment for acute spinal cord injury contains errors and inaccuracies that will necessitate a revision. The article, which has undergone initial testing in humans, was published without peer review in February 2024 on the MedRXiv platform. Although submitted to scientific journals, it was ultimately rejected, prompting the need for a thorough revision before any further attempts at publication.

In her communication, Coelho highlighted that the revised article will include significant technical corrections, adjustments to data presentation, and improved explanations of the results. Despite these challenges, the researcher remains committed to addressing the feedback received from the scientific community, particularly noting the concerns raised by other scientists and neurosurgeons regarding the completeness of the information provided in the initial release. Such scrutiny reflects the high stakes associated with publishing research that might impact clinical practices in treating spinal cord injuries.

Coelho declined to provide an interview when approached by Folha regarding the article. This situation encapsulates the typical journey of scientific research, where initial findings undergo rigorous examination before consideration for publication, especially in fields as critical as neurobiology. The response from the scientific community will likely shape not only the fate of this particular study but also the larger conversation around developing effective treatments for spinal injuries.